20Jul 2023
Personalised indocyanine‐guided lymphadenectomy for prostate cancer: a randomised clinical trial

Personalised indocyanine‐guided lymphadenectomy for prostate cancer: a randomised clinical trial

This study assesses the safety and efficacy of a personalised indocyanine‐guided pelvic lymph node dissection (PLND) against extended PLND (ePLND) during radical prostatectomy (RP). Personalised ICG‐guided PLND is a promising technique to properly stage patients with intermediate‐ and high‐risk PCa. It has shown a lower complication rate than ePLND with similar oncological outcomes at short‐term follow‐up.

  • #urology

Like

Save

Share